miRNA-214-3p, on the other hand, is upregulated in response to signaling by TGF-β1, another critically important mediator of pathophysiological events in PAH and fibrosis (Stevens at al., 2016). The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.